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THE CAUSES OF CLINICAL POLYMORPHISM IN PSORIASIS 
Psoriasis  is  considered  as  multi factorial  disease,  when  in  350 
patients there were studied different hereditary (HLA system) and 
environmental  (immunological,  biochemical  and  others)  factors 
which had contributed to the development of the predominant 
form  of  the  psoriatic  process.  The  performed  investigations 
showed  that  treatment  of  patients  with  psoriasis,  especially  its 
severe  forms,  should  be  complex  because  various  changes  in 
different body systems underlie its nature.   
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Introduction 
Psoriasis is a skin multi factorial disease widespread all over the world. According to many 
authors  2 7%  of  population  are  suffering  from  this  disease  in  the  various  countries. 
(Baker, 2001; Elberg, 1997; Langley et al., 2005; Mordovtsev et al., 2001; Rakhmatov and 
Rakhmatov,  2001;  Shilov,  2001).  Psoriasis  is  defined  as  not  isolated  dermatosis  but 
systemic disease with dominating expressions on the skin (Baker, 2001; Belyaev, 2005; 
Mordovtsev et al., 2001; Rakhmatov and Rakhmatov, 2001). Frequently the expanded skin 
lesions  and/or  severe  forms  of  the  arthropathy  syndrome  result  in  disability  of  the 
patients,  that,  consequently,  requires  to  consider  psoriasis  as  a  serious  medical social 
problem  requiring  significant  costs  for  treatment  and  rehabilitation  of  the  patients 
(Ayzatullov and Yukhimenko, 2001; Belyaev, 2005; Rakhmatov and Rakhmatov, 2001). 
The psoriasis manifests with the signs of metabolic syndrome which are responsible for 
processes of hyperproliferation and differentiation of the keratinocytes which are basis for 
morphological changes in this dermatosis. The various disorders revealed in the endocrine 
system (frequent development of diabetes mellitus), cardiovascular system (strokes and 
infarctions), liver functional disorders resulting in development of dyslipidemia as well as 
other  features  of  homeostasis  (immune  and  cytokine  system)  present  the  general 
conception of multifactorial nature of psoriasis (Griffits and Barker, 2007; Langley et al., 
2005; Rakhmatov and Rakhmatov, 2001; Wakkee et al., 2007). On the basis of this the 
methods  of  complex  treatment  for  patients  with  psoriasis  including  methods  of  anti 
cytokine therapy using biological agents, blockers of some cytokines allowing the tactics of 
treatment  to  be  changed  cardinally,  particularly  for  the  dramatically  severe  forms  of 
dermatosis (Terletskiy, 2007; Smith and Baker, 2006). 
Materials and methods 
On the basis of Medical center of Z.B.Keshileva (Almati city) during the period from 
2002 to 2010 there was performed clinical laboratory examination of 350 patients with 
psoriasis (199 males and 151 females) at the age from 18 to 65 years. Among the random 
selection in 253 (72.3%) patients the common form of disease was established, exudative 
form – in 48 (13.3%) patients, arthropathic   in 27 (7.7%), and erythrodermic form of 
dermatosis – in 22 (6.3%). 
There  were  carried  out  neurophysiological,  immunogenic,  immunological, 
immunoenzymatic,  biochemical  and  psychological  methods  of  examination  allowing Medical and Health Science Journal / MHSJ  /  ISSN: 1804-1884 (Print) 1805-5014 (Online)   
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identification of trigger factors, involving in the development and progressing psoriatic 
process as well as choice of appropriate correcting therapy for individual patient. 
Results 
In Kazakh patients with psoriasis there was revealed association with such antigens of 
histocompatibility  as  HLA A1,  HLA A9,  HLA B13,  HLA B17  and  HLA Cw3  and  in 
some clinical forms of dermatosis there were identified special haplotypes from above 
mentioned antigens. 
The hyperlipoproteinemia type IV significantly exceeding population threshold was found 
in 9.6% of patients with psoriasis, moreover there were established not only increased 
values  of  the  low density  lipoprotein  contents,  but  significant  accumulation  of 
phospholipids lysoforms in the various biological objects (blood serum, erythrocyte and 
thrombocyte membranes)  that indicates about adaptation compensation disorders in the 
patients with psoriasis. 
The considerable disorders of both cellular and humoral immunity indicating state of 
secondary immunodeficiency induced, first of all, by increase in suppressive activity that 
partially confirmed by parameters CD95+lymphocytes, responsible for apoptosis more 
changing  in  the  patients  with  psoriasis,  particularly  in  its  severe    forms.  This 
immunological  picture,  reduction  of  immunological  control,  consequently,  results  in 
development of endogenous intoxication which, in its turn, can have strong effect on the 
general progressing of psoriatic process and induce torpidity of the treatment performed. 
The investigations of neurophysiological characteristics (electroencephalogram and others) 
in 303 patients with various forms of psoriasis revealed special diffusive changes without 
identified locality with equivalents indicating about increased evoked cortex and activity of 
the structures of oral site of the brain stem (cortex, diencephalic area) in 85,5% of cases. 
Moreover, these disorders were correlated with psychological structure of the individuum 
evaluated by MMPI test. 
It  is  naturally  that  prolonged  development  of  psoriasis,  poor  efficacy  of  therapy 
performed in some cases results in psychic troubled in the patients that, in its turn, forms 
unfavorable psychoemotional state that effect on the clinical course of the main disease. 
Therefore  adequate  therapy  for  patients  with  psoriasis  demands  understanding 
psychological structure of the patients. 
The use of MMPI test allowed to characterize the state of patients with psoriasis as to be 
neurotic. The patients with unstable emotional state and increased anxiety prevailed. The 
disease aggravated premorbid state of the personality that made difficult interpersonal 
relations and resulted in the further social isolation. 
Between  genetic  and  environmental  factors  there  was  established  heterogenous 
connection  which  explained  many  various  forms  of  clinical  pictures  of  psoriasis, 
etiological causes of occurrence of severe forms of dermatosis.  The studies showed that 
presence of antigen HLA B13  was accompanied by disorders of bioelectric activity of the 
brain, for patients there were characteristic neurotic and psychotic profiles of MMPI test, 
the significant immunologic disorders, particularly of cytokine status, as well as appearance 
of the syndrome of endogenous intoxication were revealed. 
The clinical features of psoriasis with identified risk factors of dermatosis were carefully 
compared and analyzed in each patient. On the basis of the results of complex study of 
different immunogenetic, immunologic, biochemical and neurophysiological factors and 
guided by clinical signs of disease we identified special, scientifically based groups for 
further correcting therapy. 
Thus, 253 patients with the common form of psoriasis were divided into V groups. Group 
1  included  81  (32.0%)  patients  with  presence  of  large plaque  elements  of  different 
localization for which marked disorders of liver function were characteristic and neurotic Medical and Health Science Journal / MHSJ  /  ISSN: 1804-1884 (Print) 1805-5014 (Online)   
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scales of MMPI test prevailed. Group II (59  23.3%)  consisted of patients with presence 
of small plaque elements, among which  there were predominant patients with psychotic 
profiles of MMPI test, with disorders of neurophysiological parameters, and in rare cases 
there were found functional disorders of the liver and immune status. Group III (29 
11.5%)  comprised  patients  with  psoriasis  guttata  who  had  correlation  (r=0.89)  with 
immune and cytokine status (IL 4, TNF α). Antigen HLA B8 prevailed more than 2.5 
times in this group. Group IV (48 18.9%) with common form of psoriasis there were 
included patients with eruptions on the hairy part of head (sebopsoriasis) accompanied by 
intensive  skin  pruritus.  Among  these  patients  there  were  predominant  neurotic  and 
psychotic  profiles  of  MMPI  test,    dyslipidemia  was  observed  as  well  as  with  higher 
frequency antigens HLA A11, HLA B13, HLA Cw3. Group 5 (37 14.6%) had patients 
with psoriasis with predominant lesions of palmers and plants among which  there was 
noted state of secondary immunodeficiency and functional liver disorders. Among this 
group of patients the neurotic scales of MMPI test prevailed. Frequency of HLA antigens 
distribution in patients of group V was equal with those in common form of psoriasis. 
The studied 48 patients with exudative form of psoriasis were divided into two groups: 
Group I  (12 patients)  was  characterized  by  presence  of  exudative  component on  the 
psoriatic  focuses  of  any  localization,  among  which  there  were  revealed  significant 
immunologic and functional liver disorders. Among the antigens of HLA system HLA 
A3, HLA B8, HLA Cw6 prevailed; group II (36 patients) were characterized by eruptions 
in  the  area  of  large  skin  folds  (intertrigo like  form),  among  which  the  immunologic 
disorders and significant increase in TNF alpha were most important. Frequency of HLA 
antigens were similar those in group I of exudative psoriasis.  
The patients with arthropathic form of psoriasis were divided into II groups in relation to 
distribution of the skin expressions of dermatosis. Clinical picture in 18 patients (group I) 
with arthropathic form of psoriasis was characterized by damage of digital joints of hands 
and feet and multiple small  and large plaque eruptions. Among these patients there were 
revealed  significant  neurophysiological  changes  type  II  and  III,  immunologic  and 
biochemical disorders, as well as changes in parameters of cytokine status (TNF alpha). 
Antigens of HLA system, such as HLA B8, HLA B35, prevailed. In group II (9 patients) 
the  patients  with  signs  of  convulsive  syndrome  but  minimal  skin  manifestations  of 
dermatosis were studied. The disorders of immune and cytokine status, biochemical and 
neurophysiological  parameters were similar those in group 1, however in group II the 
patients were prevailed with presence of antigen HLA B27. 
The patients with psoriatic erythroderma were also divided into 2 groups: Group I (15 
patients) was characterized by universal skin process including lesions of the face, palms 
and  plants and in these patients all studied trigger factors were changed very much; 
Group  II  (7  patients)  was  interesting  by  association  of  psoriatic  erythroderma  and 
arthropathy not only of digital joints of palms and plants but also by spinal cord. In this 
patients there were noted most disorders in the cytokine system that is the basis for use of 
biological agents especially in this form of psoriasis. Antigens HLA Cw1, HLA Cw6 and 
haplotype HLA A11+HLA B13+HLA Cw1 prevailed among the most met antigens of 
HLA system. 
Conclusion  
Multifactorial nature of psoriasis presumes polymorphism of clinical manifestations of 
dermatosis,  when  there  is  genetic  determination  from  one  side  and  effect  of  various 
environmental  factors  from  other  side  (Mordovtsev  et  al.,  2001;  Terletskiy,  2007). 
Considering  psoriasis  as  systemic  disease  (Rakhmatov  and  Rakhmatov,  2001)  we  can 
suggest  functional  disorders  in  many  systems  and  organs  which  result  in  change  of 
homeostasis and should be taking into account in development of pathogenically based 
therapy  of  this  dermatosis  (Smith  and  Baker,  2006).  Of  course,  the  progress  of 
immunological  examinations,  particularly,  capacities  of  immune enzymatic  analysis, Medical and Health Science Journal / MHSJ  /  ISSN: 1804-1884 (Print) 1805-5014 (Online)   
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allowed study of special cytokines, particularly proinflammatory cytokine THF alpha that 
resulted  in  appearance  of  biological  preparations  (infliximab).  The  investigations 
performed showed that treatment of patients with psoriasis, especially its severe forms, 
should be complex because various changes in different body systems underlie its nature.   
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